| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,299 |
2,970 |
$302K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,654 |
1,586 |
$202K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,119 |
1,119 |
$133K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
935 |
907 |
$117K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
844 |
767 |
$94K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
662 |
662 |
$77K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,523 |
2,485 |
$62K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
297 |
297 |
$38K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
483 |
469 |
$15K |
| 87634 |
|
180 |
178 |
$12K |
| 87631 |
|
82 |
76 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
138 |
132 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
176 |
172 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
57 |
56 |
$4K |
| S9083 |
Global fee urgent care centers |
27 |
26 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
256 |
254 |
$4K |
| 80053 |
Comprehensive metabolic panel |
344 |
325 |
$4K |
| 96127 |
|
449 |
433 |
$3K |
| 87420 |
|
165 |
159 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
282 |
277 |
$2K |
| 87070 |
|
199 |
197 |
$2K |
| 80061 |
Lipid panel |
134 |
132 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
152 |
152 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
57 |
56 |
$1K |
| 83655 |
|
91 |
91 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
36 |
36 |
$469.01 |
| 92551 |
|
1,103 |
1,103 |
$340.60 |
| 36415 |
Collection of venous blood by venipuncture |
883 |
816 |
$247.00 |
| 85018 |
|
91 |
91 |
$215.67 |
| 82728 |
|
12 |
12 |
$163.56 |
| 84466 |
|
12 |
12 |
$153.12 |
| 90716 |
|
160 |
160 |
$138.31 |
| 90686 |
|
707 |
706 |
$69.92 |
| 36416 |
|
13 |
12 |
$3.60 |
| 90633 |
|
228 |
228 |
$0.00 |
| 90670 |
|
483 |
483 |
$0.00 |
| 90707 |
|
130 |
130 |
$0.00 |
| 99173 |
|
46 |
46 |
$0.00 |
| 96160 |
|
54 |
52 |
$0.00 |
| 90734 |
|
82 |
82 |
$0.00 |
| 90685 |
|
12 |
12 |
$0.00 |
| 90680 |
|
113 |
113 |
$0.00 |
| 90651 |
|
92 |
92 |
$0.00 |
| 90698 |
|
196 |
196 |
$0.00 |
| 90744 |
|
56 |
55 |
$0.00 |
| 90696 |
|
15 |
15 |
$0.00 |